Who
Jeffrey D. Capello
Director
Company insider
Files Form 4 as: Director, Neogen; Director, Agios Pharmaceuticals; EVP & Chief Financial Officer, Biogen; Director, Tempest Therapeutics; Director, Decoy Therapeutics; EVP & Chief Financial Officer, Boston Scientific; SVP & CFO, Revvity.
In numbers
- Trades disclosed
- 200
- Buys
- 2
- Sells
- 6
- Bought
- $200K
- Sold
- $13.6M
- Companies
- 7
- Companies where not an officer
- 4
- First trade
- 31 Jan 2006
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $120K9,804 at $12.24 | filing |
| 1 Oct 2026filed 2 Oct 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —20,558 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,927 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,927 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,950 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,950 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —2,816 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 13 Jun 2026filed 16 Jun 2026 | AGIO Agios PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,976 at $0.00 | filing |
| 27 Oct 2025filed 29 Oct 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $11K1,777 at $6.19 | filing |
| 27 Oct 2025filed 29 Oct 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code M | $11K1,777 at $6.19 | filing |
| 27 Oct 2025filed 28 Oct 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | $13K2,025 at $6.19 | filing |
| 27 Oct 2025filed 28 Oct 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code M | $13K2,025 at $6.19 | filing |
| 23 Oct 2025filed 27 Oct 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,814 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $120K19,769 at $6.07 | filing |
News
Codexis (NASDAQ:CDXS) and Revvity (NYSE:RVTY) Head-To-Head ComparisonRVTY · themarketsdaily.com · 19 Oct 2026Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)NEOG · themarketsdaily.com · 18 Oct 2026Tempest Therapeutics, Inc. (NASDAQ:TPST) Shares Shorted: Short Interest Up 73.6% in SeptemberTPST · dailypolitical.com · 17 Oct 2026Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Rep. Gilbert Ray Cisneros, Jr. Sells Shares of Revvity Inc. (NYSE:RVTY)RVTY · tickerreport.com · 14 Oct 2026Revvity (NYSE:RVTY) Stock Sale Disclosed by Rep. Gilbert Ray Cisneros, Jr.RVTY · dailypolitical.com · 14 Oct 2026Tempest Therapeutics (NASDAQ:TPST) Upgraded to "Sell" at Wall Street ZenTPST · dailypolitical.com · 11 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026
0 headlines in the last 90 days name Jeffrey D. Capello; 8 articles from the last 14 days about the 4 companies they traded most, at most three about any one of them.